Company intelligence / Profile preview

LAB Research

Ownership: Private
Employees: ~450
Development stage: Other

Overview

LAB Research was a prominent Canadian contract research organization (CRO) that provided essential non-clinical drug development services to the global biopharmaceutical and chemical industries. The company specialized in preclinical safety testing, including toxicology, immunology, and pharmacology studies required for regulatory submissions. With operations in Canada, Denmark, and Hungary, LAB Research supported clients through the early stages of drug discovery and development. In 2011, the company was acquired by CIToxLAB, and its facilities were later integrated into Charles River Laboratories following their acquisition of CIToxLAB in 2019.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on LAB Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAB Research.

Explore the full profile